Risk factors for bone metastasis from renal cell cancer-Reference-Cited by-同舟云学术

Risk factors for bone metastasis from renal cell cancer

Published:2017-11 Issue: Volume:9 Page:29-33
ISSN:2212-1374
Container-title:Journal of Bone Oncology
language:en
Short-container-title:Journal of Bone Oncology

Author:

Chen Xuan-Yin,Lan Min,Zhou Yang,Chen Wen-Zhao,Hu Dong,Liu Jia-Ming,Huang Shan-Hu,Liu Zhi-Li,Zhang Zhi-Hong

Funder

Natural Science Foundation of Jiangxi Province

Publisher

Elsevier BV

Subject

Oncology

Reference20 articles.

1. Expression of tyrosine kinase receptor AXL is associated with worse outcome of metastatic renal cell carcinomas treated with sunitinib;Zucca;Urol. Oncol.,2017

2. Surgical management of advanced and metastatic renal cell carcinoma: a multidisciplinary approach;Shinder;Front. Oncol.,2017

3. Autocrine and paracrine STIP1 signaling promote osteolytic bone metastasis in renal cell carcinoma;Wang;Oncotarget,2017

4. Review of renal cell carcinoma and its common subtypes in radiology;Low;World J. Radiol.,2016

5. Skeletal metastasis in renal cell carcinoma: current and future management options;Wood;Cancer Treat. Rev.,2012

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. SPECT/CT imaging: quantifying 99mTc-MDP concentration in the spine and pelvis;Annals of Nuclear Medicine;2024-08-18

2. Radiomics‑Clinical model based on 99mTc-MDP SPECT/CT for distinguishing between bone metastasis and benign bone disease in tumor patients;Journal of Cancer Research and Clinical Oncology;2023-07-25

4. Potential biomarkers for the early detection of bone metastases;Frontiers in Oncology;2023-06-19

5. Alkaline phosphatase combines with CT factors for differentiating small (≤ 4 cm) fat-poor angiomyolipoma from renal cell carcinoma: a multiple quantitative tool;World Journal of Urology;2023-04-24